Philips and Histolab Launch Strategic Partnership to Enhance Digital Pathology Solutions Across the Nordics 

Stockholm, Sweden - Royal Philips (NYSE: AEX PHG, : PHIA), a global leader in health technology, and Histolab, a leading provider of comprehensive histology solutions, are pleased to announce a strategic partnership aimed at expanding digital pathology solutions throughout the Nordic region. Under this collaboration, Histolab becomes the official reseller for Philips Digital Pathology Solutions in Sweden, Norway, Finland, and Denmark.

This partnership combines Philips’ cutting-edge digital pathology technology with Histolabs’ strong regional presence and deep expertise in pathology services. Philips advanced digital scanner platform delivers consistently high-quality images, with fast and accurate scanning capabilities. These systems can offer more detailed visualizations than traditional microscopy—such as the ability to highlight helicobacter pylori, which can be difficult to detect through conventional means. With a strong focus on automation, innovation, and intelligent workflow management, Histolab helps laboratories around the world operate with greater precision, efficiency and ease.

Together, the two companies will provide comprehensive, end-to-end solutions that empower laboratories across the Nordics to digitize and optimize their pathology workflows with greater precision, efficiency, and reliability.

“I am excited that Histolab will be our Channel Partner to expand our digital pathology solutions in the Nordics,” said Marion Geerligs, Digital Pathology Leader at Philips. “With Histolab’s strong relationships with hospitals and labs, this collaboration will help us further drive end-to-end workflow optimization for our customers.”

Joakim Eurenius, Managing Director at Histolab, added: “We are proud to team up with Philips as the official partner for Digital Pathology. Together, we look forward to supporting healthcare providers across the Nordics in accelerating their digital transformation journeys.”

The partnership marks a significant step in improving diagnostic accuracy, efficiency, and collaboration for pathology services across the Nordic region.